Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.597
+0.025 (4.43%)
At close: Apr 28, 2026, 4:00 PM EDT
0.581
-0.016 (-2.67%)
After-hours: Apr 28, 2026, 6:29 PM EDT
Vistagen Therapeutics Employees
Vistagen Therapeutics had 57 employees as of March 31, 2025. The number of employees increased by 17 or 42.50% compared to the previous year.
Employees
57
Change (1Y)
17
Growth (1Y)
42.50%
Revenue / Employee
$13,373
Profits / Employee
-$1,136,373
Market Cap
23.64M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Quince Therapeutics | 38 |
| Curis | 24 |
| Jasper Therapeutics | 22 |
| OSR Holdings | 22 |
| Serina Therapeutics | 13 |
| VYNE Therapeutics | 10 |
| Exicure | 8 |
| Lexaria Bioscience | 7 |
VTGN News
- 6 days ago - Vistagen Receives FDA “Study May Proceed” Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause - Business Wire
- 6 weeks ago - Vistagen Therapeutics Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 6 weeks ago - Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the Firm Regarding the Upcoming March 16th Lead Plaintiff Deadline - GlobeNewsWire
- 2 months ago - Vistagen to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Vistagen Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference - Business Wire
- 2 months ago - Vistagen Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 2 months ago - Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update - Business Wire